AmbEryn
ActiveSummary
AmbEryn has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €224,050 and a net result of €89,795. Equity is growing by ~40.9% per year across the filed fiscal years. Its solvency ranks better than 75% of 2356 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency100=
Growth78=
Track record94
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €21,000 at 30 days acceptable
Liquidity ample (current ratio 17.23 against 14.44 in 2024; short-term debt: 4.4% and cash: 45.3% of total assets), and 15.9% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
84.1%
Return on assets
33.7%
Age of the figures
9 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 23-07-2026, 8 days ahead of the deadline.
NBB · 4 filingsDeviation from the deadline
2025
8 d early
2024
30 d early
2023
13 d early
2022
4 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 4 accounts on average 14 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
27-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, abbreviated schema
Equity
€224,050▲ 21.6%
2024 · €184,255
Total assets
€266,500▲ 35.2%
2024 · €197,102
Net result
€89,795▲ 20.5%
2024 · €74,507
Working capital
€190,755▲ 10.5%
2024 · €172,607
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line2022202320242025
Operating result€64,043-€91,677▲ 43.1%€97,101▲ 5.9%€113,123▲ 16.5%
Net result€47,887within the sector's middle half-€64,628within the sector's middle half▲ 35.0%€74,507within the sector's middle half▲ 15.3%€89,795within the sector's middle half▲ 20.5%
Equity€49,287below the sector's middle half-€112,248within the sector's middle half▲ 128%€184,255within the sector's middle half▲ 64.2%€224,050within the sector's middle half▲ 21.6%
Total assets€67,053below the sector's middle half-€126,393below the sector's middle half▲ 88.5%€197,102within the sector's middle half▲ 55.9%€266,500below the sector's middle half▲ 35.2%
Debt€17,766-€14,145▼ 20.4%€12,847▼ 9.2%€42,450▲ 230%
Working capital€38,035-€97,399▲ 156%€172,607▲ 77.2%€190,755▲ 10.5%
Solvency73.5%within the sector's middle half-88.8%above the sector's middle half▲ 15.3pp93.5%above the sector's middle half▲ 4.7pp84.1%above the sector's middle half▼ 9.4pp
Staff (FTE)0below the sector's middle half
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has risen three years in a row; 2025 is 17% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €266,500
Fixed assets
€63,993 ▲ 449%
Current assets
€202,508 ▲ 9.2%
Equity and liabilities €266,500
Equity
€224,050 ▲ 21.6%
Debt
€42,450 ▲ 230%
Debt's share of the balance-sheet total rises from 6.5% to 15.9%. Equity and debt are higher.
Key figures and ratios
EBITDA
€121,973▲
2024 · €104,581
Cash flow
€98,645▲
2024 · €81,987
Current ratio
17.23▲
2024 · 14.44
Debt to equity
0.19▲
2024 · 0.07
ROE
40.1%▼
2024 · 40.4%
ROA
33.7%▼
2024 · 37.8%
Interest coverage
158.29▼
2024 · 165.69
Debt ≤ 1 year
€11,752▼
2024 · €12,847
Debt > 1 year
€30,698
Income taxes
€25,372▲
2024 · €21,963
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 26,964 companies that looked in July 2024 the way this one looks now, 1.5% went bankrupt within 24 months and 95% are still going.
- Micro
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
1.5%
went bankrupt
3.4%
stopped otherwise
95%
still going
A further 0.3% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,058 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.6% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 26,964 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | - | €5,198 | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €10,181 | €8,107 | €7,479 | €8,850 | ▲ 18.3% |
| Other operating charges640/8 | €1,648 | €380 | €688 | €581 | ▼ 15.6% |
| Gross operating margin9900 | €75,872 | €100,164 | €105,269 | €122,554 | ▲ 16.4% |
| Operating profit (loss)9901 | €64,043 | €91,677 | €97,101 | €113,123 | ▲ 16.5% |
| Financial income75/76B | - | - | - | €2,814 | - |
| Recurring financial income75 | - | - | - | €2,814 | - |
| Financial charges65/66B | €651 | €222 | €631 | €771 | ▲ 22.1% |
| Recurring financial charges65 | €651 | €222 | €631 | €771 | ▲ 22.1% |
| Profit (loss) for the period before taxes9903 | €63,391 | €91,455 | €96,470 | €115,167 | ▲ 19.4% |
| Income taxes67/77 | €15,504 | €26,827 | €21,963 | €25,372 | ▲ 15.5% |
| Profit (loss) for the period9904 | €47,887 | €64,628 | €74,507 | €89,795 | ▲ 20.5% |
| Profit (loss) for the period to be appropriated9905 | €47,887 | €64,628 | €74,507 | €89,795 | ▲ 20.5% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Assets | |||||
| Total assets20/58 | €67,053 | €126,393 | €197,102 | €266,500 | ▲ 35.2% |
| Fixed assets21/28 | €12,724 | €14,849 | €11,649 | €63,993 | ▲ 449% |
| Tangible fixed assets22/27 | €12,724 | €14,849 | €11,649 | €63,993 | ▲ 449% |
| Plant, machinery and equipment23 | - | €3,063 | €2,413 | €3,660 | ▲ 51.7% |
| Furniture and vehicles24 | €12,724 | €11,786 | €9,235 | €11,893 | ▲ 28.8% |
| Leasing and similar rights25 | - | - | - | €48,439 | - |
| Current assets29/58 | €54,329 | €111,544 | €185,454 | €202,508 | ▲ 9.2% |
| Amounts receivable within one year40/41 | - | - | €3,037 | €0 | ▼ 100% |
| Other amounts receivable41 | - | - | €3,037 | €0 | ▼ 100% |
| Current investments50/53 | - | - | €145,000 | €80,000 | ▼ 44.8% |
| Cash at bank and in hand54/58 | €54,159 | €110,663 | €35,943 | €120,668 | ▲ 236% |
| Deferred charges and accrued income490/1 | €170 | €881 | €1,473 | €1,840 | ▲ 24.9% |
| Equity and liabilities | |||||
| Total equity and liabilities10/49 | €67,053 | €126,393 | €197,102 | €266,500 | ▲ 35.2% |
| Equity10/15 | €49,287 | €112,248 | €184,255 | €224,050 | ▲ 21.6% |
| Contributions10/11 | €3,000 | €3,000 | €3,000 | €3,000 | = |
| Reserves13 | €46,287 | €109,248 | €181,255 | €220,955 | ▲ 21.9% |
| Distributable reserves133 | €46,287 | €109,248 | €181,255 | €220,955 | ▲ 21.9% |
| Profit (loss) carried forward14 | - | - | - | €95 | - |
| Amounts payable17/49 | €17,766 | €14,145 | €12,847 | €42,450 | ▲ 230% |
| Amounts payable after more than one year17 | €1,472 | - | - | €30,698 | - |
| Financial debts170/4 | €1,472 | - | - | €30,698 | - |
| Amounts payable within one year42/48 | €16,294 | €14,145 | €12,847 | €11,752 | ▼ 8.5% |
| Current portion of amounts payable after more than one year42 | €8,777 | €1,472 | - | €7,719 | - |
| Financial debts43 | €3,345 | - | - | - | - |
| Credit institutions430/8 | €3,345 | - | - | - | - |
| Trade debts44 | €725 | €433 | €629 | €2,056 | ▲ 227% |
| Suppliers440/4 | €725 | €433 | €629 | €2,056 | ▲ 227% |
| Taxes, remuneration and social security45 | €984 | €8,643 | €9,880 | €500 | ▼ 94.9% |
| Taxes450/3 | €984 | €8,643 | €9,880 | €500 | ▼ 94.9% |
| Other amounts payable47/48 | €2,462 | €3,597 | €2,338 | €1,477 | ▼ 36.8% |
| Line | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €47,887 | €64,628 | €74,507 | €89,795 | ▲ 20.5% |
| + Depreciation and write-downs630 | €10,181 | €8,107 | €7,479 | €8,850 | ▲ 18.3% |
| Operating cash flow (approximation) | €58,068 | €72,735 | €81,987 | €98,645 | ▲ 20.3% |
| Investment in fixed assets (approximation) | - | -€10,232 | -€4,279 | -€61,194 | ▼ 1,330% |
| Change in cash | - | €56,504 | -€74,719 | €84,724 | ▲ 213% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
23-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Highest result since 2022net €89,795 ▲20.5%
Operating result €113,123, net result €89,795, both a record.
31-12
Financial
Equity above €200,000Eq €224,050 ▲21.6%
4 profitable years in a row build equity to €224,050.
01-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Equity above €150,000Eq €184,255 ▲64.2%
3 profitable years in a row build equity to €184,255.
18-07
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Liquidity doublescurrent ratio 7.89
Current ratio from 3.33 to 7.89; short-term debt falls from €16,294 to €14,145.
31-12
Financial
Equity above €100,000Eq €112,248 ▲128%
2 profitable years in a row build equity to €112,248.
27-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Bertem · 1 establishment unit since 2021
Ground area
1,716 m²
Building footprint
156 m²
Volume, LiDAR
813 m³
Parcel 24052A0345/00N004, Flanders · tallest building 8.0 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
AmbEryn
since 20212.320.490.616
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 24052A0345/00N004 | Flanders | 1,716 m² | 1 · 156 m² | 8.0 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
CABINET D'OPHTALMOLOGIE DUCHATEAU
BE 0895.869.036
Fléron · Eq €224,106
DR. COLTURA MARIO , ANESTHESIE
BE 0816.756.232
Grimbergen · Eq €223,956
Dr. Ph. Reyntjens
BE 0832.945.433
Schoten · Eq €224,162
DOKTER TEMMERMAN MDL
BE 0662.532.170
Arendonk · Eq €223,933
CHIRURGIE ORTHOPEDIQUE Dr Dan SCORPIE
BE 0769.415.282
Aubange · Eq €223,929
Of 16,631 companies in sector 86220 we hold annual accounts for 7,985. 6,669 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded26-07-2021
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0771725169
Registered
27-03-2026
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.